MedPacto, Inc. (KOSDAQ:235980)

MedPacto Statistics

Total Valuation

MedPacto has a market cap or net worth of KRW 157.32 billion. The enterprise value is 110.92 billion.

Market Cap	157.32B
Enterprise Value	110.92B

Important Dates

The next estimated earnings date is Tuesday, November 11, 2025.

Earnings Date	Nov 11, 2025
Ex-Dividend Date	n/a

Share Statistics

MedPacto has 34.28 million shares outstanding. The number of shares has increased by 23.87% in one year.

Current Share Class	34.28M
Shares Outstanding	34.28M
Shares Change (YoY)	+23.87%
Shares Change (QoQ)	+2.07%
Owned by Insiders (%)	11.97%
Owned by Institutions (%)	0.16%
Float	25.23M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	123.92
PB Ratio	3.00
P/TBV Ratio	3.01
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-9.40
EV / Sales	87.37
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-10.05

Financial Position

The company has a current ratio of 36.77, with a Debt / Equity ratio of 0.04.

Current Ratio	36.77
Quick Ratio	35.49
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	-0.18
Interest Coverage	-146.94

Financial Efficiency

Return on equity (ROE) is -21.44% and return on invested capital (ROIC) is -14.90%.

Return on Equity (ROE)	-21.44%
Return on Assets (ROA)	-13.62%
Return on Invested Capital (ROIC)	-14.90%
Return on Capital Employed (ROCE)	-24.71%
Revenue Per Employee	22.67M
Profits Per Employee	-210.80M
Employee Count	56
Asset Turnover	0.02
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -26.79% in the last 52 weeks. The beta is 0.62, so MedPacto's price volatility has been lower than the market average.

Beta (5Y)	0.62
52-Week Price Change	-26.79%
50-Day Moving Average	4,375.20
200-Day Moving Average	3,909.05
Relative Strength Index (RSI)	47.64
Average Volume (20 Days)	611,978

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, MedPacto had revenue of KRW 1.27 billion and -11.80 billion in losses. Loss per share was -346.94.

Revenue	1.27B
Gross Profit	118.03M
Operating Income	-13.36B
Pretax Income	-11.80B
Net Income	-11.80B
EBITDA	-12.02B
EBIT	-13.36B
Loss Per Share	-346.94

Balance Sheet

The company has 48.36 billion in cash and 1.96 billion in debt, giving a net cash position of 46.40 billion or 1,353.69 per share.

Cash & Cash Equivalents	48.36B
Total Debt	1.96B
Net Cash	46.40B
Net Cash Per Share	1,353.69
Equity (Book Value)	52.43B
Book Value Per Share	1,529.80
Working Capital	50.23B

Cash Flow

In the last 12 months, operating cash flow was -10.69 billion and capital expenditures -348.44 million, giving a free cash flow of -11.04 billion.

Operating Cash Flow	-10.69B
Capital Expenditures	-348.44M
Free Cash Flow	-11.04B
FCF Per Share	-322.03

Margins

Gross Margin	9.30%
Operating Margin	-1,052.17%
Pretax Margin	-929.81%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

MedPacto does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-23.87%
Shareholder Yield	n/a
Earnings Yield	-7.50%
FCF Yield	-7.02%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on May 13, 2020. It was a forward split with a ratio of 2.

Last Split Date	May 13, 2020
Split Type	Forward
Split Ratio	2

Scores

MedPacto has an Altman Z-Score of 27.93 and a Piotroski F-Score of 2.

Altman Z-Score	27.93
Piotroski F-Score	2